UK markets closed

Anavex Life Sciences Corp. (AVXL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.1700-0.3300 (-7.33%)
At close: 04:00PM EDT
4.1700 0.00 (0.00%)
After hours: 04:07PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
30/09/2019
Cash flows from operating activities
Net income
-40,594
-47,505
-47,978
-37,909
-26,280
-
Stock-based compensation
11,991
16,370
18,379
8,231
4,877
-
Change in working capital
-3,873
2,505
5,361
-706
116.518
-
Accounts payable
-2,555
497
-914
751
465.722
-
Other working capital
-32,476
-27,785
-24,238
-30,384
-21,287
-
Other non-cash items
-
845
-
-
-
35.375
Net cash provided by operating activities
-32,476
-27,785
-24,238
-30,384
-21,287
-
Cash flows from financing activities
Common stock issued
16,900
27,875
20,985
153,219
28,754
-
Other financing activities
-
-
-707
-5,551
-403.764
-50
Net cash used provided by (used for) financing activities
18,395
29,651
21,288
153,243
28,350
-
Net change in cash
-14,081
1,866
-2,950
122,859
7,063
-
Cash at beginning of period
153,467
149,158
152,108
29,249
22,186
-
Cash at end of period
139,386
151,024
149,158
152,108
29,249
-
Free cash flow
Operating cash flow
-32,476
-27,785
-24,238
-30,384
-21,287
-
Free cash flow
-32,476
-27,785
-24,238
-30,384
-21,287
-